Edwards Lifesciences Corp Stock Z Score

EW Stock

USD 71.27 0.79 1.12%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Edwards Lifesciences Piotroski F Score and Edwards Lifesciences Valuation analysis.

Capital Lease Obligations is likely to climb to about 103.8 M in 2024, whereas Capital Surpluse is likely to drop slightly above 1.2 B in 2024. At this time, Edwards Lifesciences' Income Before Tax is fairly stable compared to the past year. Total Other Income Expense Net is likely to climb to about 67.2 M in 2024, whereas Interest Expense is likely to drop slightly above 10.6 M in 2024.

Edwards Lifesciences Corp Company Z Score Analysis

Edwards Lifesciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Edwards Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Edwards Lifesciences is extremely important. It helps to project a fair market value of Edwards Stock properly, considering its historical fundamentals such as Z Score. Since Edwards Lifesciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Edwards Lifesciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Edwards Lifesciences' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Net Receivables	Good Will	Total Liab	Total Current Assets	Net Debt	Accounts Payable	Long Term Debt	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Treasury Stock	Short Term Investments	Net Tangible Assets	Capital Surpluse	Long Term Investments	Long Term Debt Total	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.92	0.97	0.7	0.76	0.96	-0.68	0.73	0.4	-0.62	0.54	0.92	0.97	0.46	-0.68	0.28	0.97	0.88	0.75	0.6	0.27	0.05	0.86	0.89	0.83
Total Stockholder Equity	0.99		0.95	0.97	0.66	0.67	0.94	-0.68	0.75	0.34	-0.66	0.53	0.94	0.99	0.39	-0.69	0.24	0.99	0.85	0.73	0.53	0.27	0.05	0.91	0.92	0.87
Retained Earnings	0.92	0.95		0.93	0.45	0.53	0.91	-0.66	0.58	0.35	-0.51	0.37	0.91	0.95	0.41	-0.78	0.3	0.96	0.78	0.6	0.57	0.42	0.02	0.9	0.85	0.84
Net Receivables	0.97	0.97	0.93		0.61	0.68	0.95	-0.75	0.67	0.28	-0.62	0.47	0.89	0.97	0.52	-0.64	0.2	0.95	0.84	0.64	0.53	0.29	0.05	0.85	0.9	0.8
Good Will	0.7	0.66	0.45	0.61		0.81	0.56	-0.35	0.88	0.37	-0.74	0.76	0.59	0.64	0.15	-0.25	-0.07	0.61	0.79	0.68	0.34	-0.08	-0.05	0.58	0.69	0.58
Total Liab	0.76	0.67	0.53	0.68	0.81		0.74	-0.5	0.61	0.6	-0.37	0.39	0.63	0.64	0.59	-0.54	0.35	0.62	0.89	0.75	0.68	0.07	-0.05	0.54	0.62	0.55
Total Current Assets	0.96	0.94	0.91	0.95	0.56	0.74		-0.76	0.55	0.44	-0.47	0.39	0.85	0.92	0.59	-0.71	0.41	0.92	0.85	0.62	0.69	0.33	0.13	0.78	0.83	0.73
Net Debt	-0.68	-0.68	-0.66	-0.75	-0.35	-0.5	-0.76		-0.44	-0.26	0.42	-0.11	-0.63	-0.68	-0.61	0.6	-0.06	-0.68	-0.63	-0.36	-0.48	-0.26	-0.51	-0.55	-0.75	-0.54
Accounts Payable	0.73	0.75	0.58	0.67	0.88	0.61	0.55	-0.44		0.21	-0.85	0.7	0.73	0.75	0.02	-0.34	-0.19	0.74	0.72	0.71	0.2	0.0	0.11	0.76	0.83	0.77
Long Term Debt	0.4	0.34	0.35	0.28	0.37	0.6	0.44	-0.26	0.21		-0.08	0.11	0.3	0.29	0.28	-0.7	0.39	0.32	0.6	0.44	0.93	0.4	0.01	0.21	0.26	0.21
Short Term Debt	-0.62	-0.66	-0.51	-0.62	-0.74	-0.37	-0.47	0.42	-0.85	-0.08		-0.67	-0.6	-0.68	0.1	0.18	0.25	-0.66	-0.54	-0.49	-0.09	0.2	-0.09	-0.62	-0.75	-0.63
Intangible Assets	0.54	0.53	0.37	0.47	0.76	0.39	0.39	-0.11	0.7	0.11	-0.67		0.44	0.5	-0.26	0.02	-0.29	0.49	0.41	0.35	0.08	0.13	-0.01	0.41	0.49	0.39
Common Stock	0.92	0.94	0.91	0.89	0.59	0.63	0.85	-0.63	0.73	0.3	-0.6	0.44		0.95	0.35	-0.73	0.18	0.95	0.77	0.76	0.48	0.23	0.07	0.91	0.87	0.97
Property Plant Equipment	0.97	0.99	0.95	0.97	0.64	0.64	0.92	-0.68	0.75	0.29	-0.68	0.5	0.95		0.39	-0.67	0.19	0.99	0.83	0.7	0.49	0.25	0.06	0.92	0.93	0.9
Current Deferred Revenue	0.46	0.39	0.41	0.52	0.15	0.59	0.59	-0.61	0.02	0.28	0.1	-0.26	0.35	0.39		-0.48	0.53	0.37	0.56	0.32	0.53	0.14	-0.02	0.33	0.39	0.26
Treasury Stock	-0.68	-0.69	-0.78	-0.64	-0.25	-0.54	-0.71	0.6	-0.34	-0.7	0.18	0.02	-0.73	-0.67	-0.48		-0.43	-0.71	-0.69	-0.65	-0.82	-0.49	-0.07	-0.64	-0.58	-0.66
Short Term Investments	0.28	0.24	0.3	0.2	-0.07	0.35	0.41	-0.06	-0.19	0.39	0.25	-0.29	0.18	0.19	0.53	-0.43		0.26	0.34	0.32	0.5	-0.03	-0.21	0.24	0.09	0.15
Net Tangible Assets	0.97	0.99	0.96	0.95	0.61	0.62	0.92	-0.68	0.74	0.32	-0.66	0.49	0.95	0.99	0.37	-0.71	0.26		0.82	0.71	0.51	0.27	0.08	0.93	0.92	0.89
Capital Surpluse	0.88	0.85	0.78	0.84	0.79	0.89	0.85	-0.63	0.72	0.6	-0.54	0.41	0.77	0.83	0.56	-0.69	0.34	0.82		0.74	0.71	0.19	-0.07	0.78	0.83	0.71
Long Term Investments	0.75	0.73	0.6	0.64	0.68	0.75	0.62	-0.36	0.71	0.44	-0.49	0.35	0.76	0.7	0.32	-0.65	0.32	0.71	0.74		0.47	0.02	-0.13	0.69	0.61	0.73
Long Term Debt Total	0.6	0.53	0.57	0.53	0.34	0.68	0.69	-0.48	0.2	0.93	-0.09	0.08	0.48	0.49	0.53	-0.82	0.5	0.51	0.71	0.47		0.49	0.03	0.36	0.42	0.34
Short Long Term Debt	0.27	0.27	0.42	0.29	-0.08	0.07	0.33	-0.26	0.0	0.4	0.2	0.13	0.23	0.25	0.14	-0.49	-0.03	0.27	0.19	0.02	0.49		0.06	0.17	0.14	0.11
Cash And Equivalents	0.05	0.05	0.02	0.05	-0.05	-0.05	0.13	-0.51	0.11	0.01	-0.09	-0.01	0.07	0.06	-0.02	-0.07	-0.21	0.08	-0.07	-0.13	0.03	0.06		0.01	0.23	0.06
Net Invested Capital	0.86	0.91	0.9	0.85	0.58	0.54	0.78	-0.55	0.76	0.21	-0.62	0.41	0.91	0.92	0.33	-0.64	0.24	0.93	0.78	0.69	0.36	0.17	0.01		0.92	0.93
Net Working Capital	0.89	0.92	0.85	0.9	0.69	0.62	0.83	-0.75	0.83	0.26	-0.75	0.49	0.87	0.93	0.39	-0.58	0.09	0.92	0.83	0.61	0.42	0.14	0.23	0.92		0.87
Capital Stock	0.83	0.87	0.84	0.8	0.58	0.55	0.73	-0.54	0.77	0.21	-0.63	0.39	0.97	0.9	0.26	-0.66	0.15	0.89	0.71	0.73	0.34	0.11	0.06	0.93	0.87

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Edwards Lifesciences

According to the company's disclosures, Edwards Lifesciences Corp has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Edwards Lifesciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Edwards Lifesciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Edwards Lifesciences' managers, analysts, and investors.

Environmental

Governance

Social

Edwards Lifesciences Institutional Holders

Institutional Holdings refers to the ownership stake in Edwards Lifesciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Edwards Lifesciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Edwards Lifesciences' value.

		Shares
Brown Advisory Holdings Inc	2024-09-30	7.6 M
T. Rowe Price Associates, Inc.	2024-06-30	7.3 M
Ninety One Uk Limited	2024-09-30	7.3 M
Ubs Asset Mgmt Americas Inc	2024-09-30	6 M
Amvescap Plc.	2024-06-30	5.9 M
Hhg Plc	2024-06-30	5.4 M
Legal & General Group Plc	2024-06-30	5.4 M
Northern Trust Corp	2024-09-30	5.3 M
Sands Capital Management, Llc	2024-09-30	5.3 M
Vanguard Group Inc	2024-09-30	62.6 M
Blackrock Inc	2024-06-30	51 M

Edwards Fundamentals

	Return On Equity	0.19
	Return On Asset	0.11
	Profit Margin	0.66 %
	Operating Margin	0.29 %
	Current Valuation	37.83 B
	Shares Outstanding	589.8 M
	Shares Owned By Insiders	0.91 %
	Shares Owned By Institutions	85.84 %
	Number Of Shares Shorted	7.7 M
	Price To Earning	32.77 X
	Price To Book	4.35 X
	Price To Sales	6.66 X
	Revenue	6 B
	Gross Profit	4.3 B
	EBITDA	1.53 B
	Net Income	1.4 B
	Cash And Equivalents	769 M
	Cash Per Share	2.81 X
	Total Debt	694.9 M
	Debt To Equity	0.11 %
	Current Ratio	3.83 X
	Book Value Per Share	16.18 X
	Cash Flow From Operations	895.8 M
	Short Ratio	1.31 X
	Earnings Per Share	2.62 X
	Price To Earnings To Growth	6.47 X
	Target Price	76.39
	Number Of Employees	19.8 K
	Beta	1.12
	Market Capitalization	42.04 B
	Total Asset	9.36 B
	Retained Earnings	8.99 B
	Working Capital	2.84 B
	Current Asset	2.05 B
	Current Liabilities	476.2 M
	Net Asset	9.36 B

About Edwards Lifesciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Edwards Lifesciences Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Edwards Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Edwards Lifesciences Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Edwards Lifesciences Corp Stock Z Score

Edwards Lifesciences Corp Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Edwards Z Score Driver Correlations

Edwards Lifesciences ESG Sustainability

Edwards Lifesciences Institutional Holders

Edwards Fundamentals

About Edwards Lifesciences Fundamental Analysis

Also Currently Popular

Additional Tools for Edwards Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY